Alder BioPharmaceuticals Licenses Clazakizumab Rights to Vitaeris
Posted on08 May 2016
Comments0
Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, and Vitaeris Inc., a newly formed company that will pursue innovative... Read More